Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients.
Transplantation
; 103(9): 1903-1915, 2019 09.
Article
em En
| MEDLINE
| ID: mdl-30801523
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transplante de Fígado
/
Síndrome de Crigler-Najjar
/
Transplante de Células-Tronco
/
Distúrbios Congênitos do Ciclo da Ureia
/
Fígado
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article